Characterization of 3′,5′ cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: Absence of functional PDE6

Molecular Vision

Volumn 10, Issue , 2004, Pages 738-749

  White, J Brandon ^a,c   Thompson, W Joseph ^b   Pittler, Steven J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b OSI PHARMACEUTICALS INC   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ADENOVIRUS VECTOR; BUTYRIC ACID DERIVATIVE; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC GMP; DIPYRIDAMOLE; DNA; ENZYME ANTIBODY; ISOENZYME; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE VI; PROTEASOME; PROTEIN KINASE (CALCIUM,CALMODULIN); ROLIPRAM; SULFUR 35; UNCLASSIFIED DRUG; ZAPRINAST; ZINC DERIVATIVE; CYCLIC GMP PHOSPHODIESTERASE; PHOSPHODIESTERASE 6;

ANTIGEN RECOGNITION; ARTICLE; CANCER CELL; CELL FREE SYSTEM; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME STABILITY; ENZYME SUBUNIT; ENZYME SYNTHESIS; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; IMMUNOPRECIPITATION; IN VITRO STUDY; ION EXCHANGE CHROMATOGRAPHY; ISOLATION PROCEDURE; ISOTOPE LABELING; PHOTORECEPTOR CELL; PLASMID; POLYMERASE CHAIN REACTION; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN STRUCTURE; RETINA CONE; RETINA ROD; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; WESTERN BLOTTING; CELL CULTURE; ENZYMOLOGY; EYE TUMOR; GEL CHROMATOGRAPHY; GENETICS; HUMAN; METABOLISM;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; CYCLIC GMP; EYE NEOPLASMS; HUMANS; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES; RETINOBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 16544385309     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Essayan DM. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 2001; 108:671-80.
2. Francis SH, Turko IV, Corbin JD. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 2001; 65:1-52.
3. Baehr W, Devlin MJ, Applebury ML. Isolation and characterization of cGMP phosphodiesterase from bovine rod outer segments. J Biol Chem 1979; 254:11699-77.
4. Gillespie PG, Beavo JA. Characterization of a bovine cone photoreceptor phosphodiesterase purified by cyclic GMP-sepharose chromatography. J Biol Chem 1988; 263:8133-41.
5. Hamilton SE, Hurley JB. A phosphodiesterase inhibitor specific to a subset of bovine retinal cones. J Biol Chem 1990; 265:11259-64.
6. Gillespie PG, Prusti RK, Apel ED, Beavo JA. A soluble form of bovine rod photoreceptor phosphodiesterase has a novel 15-kDa subunit. J Biol Chem 1989; 264:12187-93.
7. Florio SK, Prusti RK, Beavo JA. Solubilization of membrane-bound rod phosphodiesterase by the rod phosphodiesterase recombinant delta subunit. J Biol Chem 1996; 271:24036-47.
8. Mou H, Grazio HJ 3rd, Cook TA, Beavo JA, Cote RH. cGMP binding to noncatalytic sites on mammalian rod photoreceptor phosphodiesterase is regulated by binding of its gamma and delta subunits. J Biol Chem 1999; 274:18813-20.
9. Cook TA, Ghomashchi F, Gelb MH, Florio SK, Beavo JA. The delta subunit of type 6 phosphodiesterase reduces light-induced cGMP hydrolysis in rod outer segments. J Biol Chem 2001; 276:5248-55.
10. Linari M, Ueffing M, Manson F, Wright A, Meitinger T, Becker J. The retinitis pigmentosa GTPase regulator, RPGR, interacts with the delta subunit of rod cyclic GMP phosphodiesterase. Proc Natl Acad Sci U S A 1999; 96:1315-20.
11. Hanzal-Bayer M, Renault L, Roversi P, Wittinghofer A, Hillig RC. The complex of Arl2-GTP and PDE delta: from structure to function. EMBO J 2002; 21:2095-106.
12. Marzesco AM, Galli T, Louvard D, Zahraoui A. The rod cGMP phosphodiesterase delta subunit dissociates the small GTPase Rab13 from membranes. J Biol Chem 1998; 273:22340-5.
13. Brown RL, Stryer L. Expression in bacteria of functional inhibitory subunit of retinal rod cGMP phosphodiesterase. Proc Natl Acad Sci U S A 1989; 86:4922-6.
14. Qin N, Pittler SJ, Baehr W. In vitro isoprenylation and membrane association of mouse rod photoreceptor cGMP phosphodiesterase alpha and beta subunits expressed in bacteria. J Biol Chem 1992; 267:8458-63.
15. Piriev NI, Yamashita C, Samuel G, Farber DB. Rod photoreceptor cGMP-phosphodiesterase: analysis of alpha and beta subunits expressed in human kidney cells. Proc Natl Acad Sci U S A 1993; 90:9340-4.
16. Qin N, Baehr W. Expression of mouse rod photoreceptor cGMP phosphodiesterase gamma subunit in bacteria. FEBS Lett 1993; 321:6-10.
17. Qin N, Baehr W. Expression and mutagenesis of mouse rod photoreceptor cGMP phosphodiesterase. J Biol Chem 1994; 269:3265-71.
18. Piriev NI, Yamashita CK, Shih J, Farber DB. Expression of cone photoreceptor cGMP-phosphodiesterase alpha' subunit in Chinese hamster ovary, 293 human embryonic kidney, and Y79 retinoblastoma cells. Mol Vis 2003; 9:80-6 .
19. Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu EW, Tralka TS, Wilcox JL. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 1974; 53:347-60.
20. McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 1977; 37:1003-10.
21. Hurwitz RL, Bogenmann E, Font RL, Holcombe V, Clark D. Expression of the functional cone phototransduction cascade in retinoblastoma. J Clin Invest 1990; 85:1872-8.
22. Wiechmann AF. Recoverin in cultured human retinoblastoma cells: enhanced expression during morphological differentiation. J Neurochem 1996; 67:105-10.
23. Di Polo A, Farber DB. Rod photoreceptor-specific gene expression in human retinoblastoma cells. Proc Natl Acad Sci U S A 1995; 92:4016-20.
24. Liu YP, Wong VG, Chabner BA. Cyclic nucleotide phosphodiesterase and protein activator in human cancer cell lines and Brown-Pearce carcinoma. J Natl Cancer Inst 1977; 59:1605-9.
25. White JB, Taylor RE, Pittler SJ. Reproducible high efficiency gene transfer into Y79 retinoblastoma cells using adenofection. J Neurosci Methods 2001; 106:1-7.
26. Thompson WJ, Brooker G, Appleman MM. Assay of cyclic nucleotide phosphodiesterases with radioactive substrates. Methods Enzymol 1974; 38:205-12.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
28. Strada SJ, Martin MW, Thompson WJ. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984; 16:13-29.
29. Fagan RJ, Lazaris-Karatzas A, Sonenberg N, Rozen R. Translational control of ornithine aminotransferase. Modulation by initiation factor eIF-4E. J Biol Chem 1991; 266:16518-23.
30. Thompson WJ. Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol Ther 1991; 51:13-33.
31. Gardner C, Robas N, Cawkill D, Fidock M. Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 2000; 272:186-92.
32. Catty P, Deterre P. Activation and solubilization of the retinal cGMP-specific phosphodiesterase by limited proteolysis. Role of the C-terminal domain of the beta-subunit. Eur J Biochem 1991; 199:263-9.
33. Pittler SJ, Baehr W. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci U S A 1991; 88:8322-6.
34. Tsang SH, Gouras P, Yamashita CK, Kjeldbye H, Fisher J, Farber DB, Goff SP. Retinal degeneration in mice lacking the gamma subunit of the rod cGMP phosphodiesterase. Science 1996; 272:1026-9.
35. Tsang SH, Yamashita CK, Lee WH, Lin CS, Goff SP, Gouras P, Farber DB. The positive role of the carboxyl terminus of the gamma subunit of retinal cGMP-phosphodiesterase in maintaining phosphodiesterase activity in vivo. Vision Res 2002; 42:439-45.
36. Huang SH, Pittler SJ, Huang X, Oliveira L, Berson EL, Dryja TP. Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase. Nat Genet 1995; 11:468-71.
37. McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP. Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci U S A 1995; 92:3249-53.
38. Pittler SJ, Baehr W, Wasmuth JJ, McConnell DG, Champagne MS, vanTuinen P, Ledbetter D, Davis RL. Molecular characterization of human and bovine rod photoreceptor cGMP phosphodiesterase alpha-subunit and chromosomal localization of the human gene. Genomics 1990; 6:272-83.
39. Mohamed MK, Taylor RE, Feinstein DS, Huang X, Pittler SJ. Structure and upstream region characterization of the human gene encoding rod photoreceptor cGMP phosphodiesterase alpha-subunit. J Mol Neurosci 1998; 10:235-50.
40. Collins C, Hutchinson G, Kowbel D, Riess O, Weber B, Hayden MR. The human beta-subunit of rod photoreceptor cGMP phosphodiesterase: complete retinal cDNA sequence and evidence for expression in brain. Genomics 1992; 13:698-704.
41. Piriev NI, Khramtsov NV, Lipkin VM. Cloning and characterization of the gene encoding the cGMP-phosphodiesterase gamma-subunit of human rod photoreceptor cells. Gene 1994; 151:297-301.
42. Li N, Florio SK, Pettenati MJ, Rao PN, Beavo JA, Baehr W. Characterization of human and mouse rod cGMP phosphodiesterase delta subunit (PDE6D) and chromosomal localization of the human gene. Genomics 1998; 49:76-82.
43. Cote RH, Brunnock MA. Intracellular cGMP concentration in rod photoreceptors is regulated by binding to high and moderate affinity cGMP binding sites. J Biol Chem 1993; 268:17190-8.
44. Kyritsis A, Koh SW, Chader GJ. Modulators of cyclic AMP in monolayer cultures of Y-79 retinoblastoma cells: partial characterization of the response with VIP and glucagon. Curr Eye Res 1984; 3:339-43.
45. Taylor A, Shang F, Obin M. Relationships between stress, protein damage, nutrition, and age-related eye diseases. Mol Aspects Med 1997; 18:305-414.
46. Sonnenburg WK, Rybalkin SD, Bornfeldt KE, Kwak KS, Rybalkina IG, Beavo JA. Identification, quantitation, and cellular localization of PDE1 calmodulin-stimulated cyclic nucleotide phosphodiesterases. Methods 1998; 14:3-19.
47. Piri N, Yamashita CK, Shih J, Akhmedov NB, Farber DB. Differential expression of rod photoreceptor cGMP-phosphodiesterase alpha and beta subunits: mRNA and protein levels. J Biol Chem 2003; 278:36999-7005.
48. He F, Seryshev AB, Cowan CW, Wensel TG. Multiple zinc binding sites in retinal rod cGMP phosphodiesterase, PDE6alpha beta. J Biol Chem 2000; 275:20572-7.
49. Deng MH, Lopez G-Coviella I, Lynch HJ, Wurtman RJ. Melatonin and its precursors in Y79 human retinoblastoma cells: effect of sodium butyrate. Brain Res 1991; 561:274-8.
50. Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986; 234:364-8.
51. Knight JK, Raymond PA. Time course of opsin expression in developing rod photoreceptors. Development 1990; 110:1115-20.
52. Timmers AM, Newton BR, Hauswirth WW. Synthesis and stability of retinal photoreceptor mRNAs are coordinately regulated during bovine fetal development. Exp Eye Res 1993; 56:257-65.
53. Gonzalez-Fernandez F, Van Niel E, Edmonds C, Beaver H, Nickerson JM, Garcia-Fernandez JM, Campohiaro PA, Foster RG. Differential expression of interphotoreceptor retinoid-binding protein, opsin, cellular retinaldehyde-binding protein, and basic fibroblastic growth factor. Exp Eye Res 1993; 56:411-27. Erratum in: Exp Eye Res 1993; 57:127.
54. van Ginkel PR, Hauswirth WW. Parallel regulation of fetal gene expression in different photoreceptor cell types. J Biol Chem 1994; 269:4986-92.
55. He L, Campbell ML, Srivastava D, Blocker YS, Harris JR, Swaroop A, Fox DA. Spatial and temporal expression of AP-1 responsive rod photoreceptor genes and bZIP transcription factors during development of the rat retina. Mol Vis 1998; 4:32 .
56. DesJardin LE, Hauswirth WW. Developmentally important DNA elements within the bovine opsin upstream region. Invest Ophthalmol Vis Sci 1996; 37:154-65.
57. Kyritsis AP, Tsokos M, Triche TJ, Chader GJ. Retinoblastoma: a primitive tumor with multipotential characteristics. Invest Ophthalmol Vis Sci 1986; 27:1760-4.
58. Bogenmann E. Retinoblastoma cell differentiation in culture. Int J Cancer 1986; 38:883-7.
59. Chader GJ. Multipotential differentiation of human Y-79 retinoblastoma cells in attachment culture. Cell Differ 1987; 20:209-16.
60. Ramamurthy V, Niemi GA, Reh TA, Hurley JB. From the Cover: Leber congenital amaurosis linked to AIPL1: A mouse model reveals destabilization of cGMP phosphodiesterase. Proc Natl Acad Sci U S A 2004; 101:13897-902.
61. Liu X, Bulgakov OV, Wen XH, Woodruff ML, Pawlyk B, Yang J, Fain GL, Sandberg MA, Makino CL, Li T. From the Cover: AIPL1, the protein that is defective in Leber congenital amaurosis, is essential for the biosynthesis of retinal rod cGMP phosphodiesterase. Proc Natl Acad Sci U S A 2004; 101:13903-8.
62. White JB, Pittler SJ. Translational control of photoreceptor phosphodiesterase? Invest. Ophthalmol. Vis. Sci. Suppl. 2001; 42: S351
63. Dick LR, Cruikshank AA, Destree AT, Grenier L, McCormack TA, Melandri FD, Nunes SL, Palombella VJ, Parent LA, Plamondon L, Stein RL. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J Biol Chem 1997; 272:182-8.
64. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995; 268:726-31.
65. Maurice DH, Palmer D, Tilley DG, Dunkerley HA, Netherton SJ, Raymond DR, Elbatarny HS, Jimmo SL. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 2003; 64:533-46.
66. Zoraghi R, Kunz S, Gong K, Seebeck T. Characterization of TbPDE2A, a novel cyclic nucleotide-specific phosphodiesterase from the protozoan parasite Trypanosoma brucei. J Biol Chem 2001; 276:11559-66.
67. D'Amours MR, Granovsky AE, Artemyev NO, Cote RH. Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme. Mol Pharmacol 1999; 55:508-14.